Rate My Professor Marilyn Saulsbury

Dr. Marilyn Saulsbury is Associate Professor and Chairperson of the Department of Pharmaceutical Sciences in the Hampton University School of Pharmacy. Holding a Bachelor of Science in Pharmacy, Ph.D., and licensed as a Registered Pharmacist (R.Ph.), she brings approximately twenty-five years of higher education experience and thirty years in pharmacy practice, including roles as Pharmacy Manager at Phar-Mor, Inc., hospital pharmacist, compounding pharmacist, and community pharmacist. At Hampton University, one of the first faculty hires in the School of Pharmacy, she advanced from Assistant Professor to tenured Associate Professor. Dr. Saulsbury contributed to the school's initial Accreditation Council for Pharmacy Education application, developed courses such as Applied Anatomy and Physiology Lecture/Laboratory and Drug and Disease State Management modules, and teaches content in Health and Basic Medical Sciences, including Pharmacology, Pathophysiology, Physiology, Health Disparities, Physical Therapy Pharmacology, and Nursing Pharmacotherapy. She has served as adjunct faculty in the School of Nursing at Old Dominion University and the South University Virginia Beach Nursing Practice program. Her service includes Faculty Trustee on the Hampton University Board of Trustees, Chair of the Committee on Faculty Research, representative to the Committee on Admissions, member of the Program Review Committee and 2018 SACS Reaffirmation Committee, co-advisor of Alpha Kappa Mu Honor Society, faculty advisor to the HUSOP Pre-Pharmacy Club, and Graduate Advisor for the undergraduate chapter of Alpha Kappa Alpha Sorority, Incorporated.

Dr. Saulsbury's research expertise encompasses pharmacology, cardiovascular physiology, endocrine physiology, and health disparities, with focus areas including cancer genomics and proteomics, biomarkers in renal cell carcinoma, lipophilic pro-drugs and cytotoxicity in cancer cells, dispositional traits in pharmacy education, oxidative stress, toxin-induced apoptosis such as by chlorpyrifos, and epigenetics effects of dioxin. An active biomedical researcher and grant-writer, she has served as principal investigator or co-investigator on four investigator-initiated awards from the NIH (MBRS-SCORE, MIDARP, NCI-P20) and CDC-ATSDR, totaling approximately five million dollars. Key publications include Heyliger et al. (2022) "Prognostic Relevance of ZNF844 and Chr 19p13.2 KRAB-Zinc Proteins in Clear Cell Renal Carcinoma" (Cancer Genomics & Proteomics, 19:305-327); Heyliger et al. (2021) "The Identification of Zinc Finger Protein 433 as a Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma" (Biomolecules, 11(8):1193); Saulsbury et al. (2011) "Effect of Dispositional Traits on Pharmacy Students’ Attitudes Toward Cheating" (American Journal of Pharmaceutical Education, 75(4):Article 69); and Saulsbury et al. (2008) "Characterization of Chlorpyrifos-Induced Apoptosis in Placental Choriocarcinoma Cells" (Toxicology, 244(2-3):98-110). She maintains memberships in the Virginia Pharmacists Association and American Pharmacists Association.